EBQ:San Francisco Syncope Rule: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
|||
| Line 16: | Line 16: | ||
}} | }} | ||
==Clinical Question== | ==Clinical Question== | ||
Can the San Francisco Syncope Rule be used in clinical practice to risk stratify patients presenting with syncope? | |||
==Conclusion== | ==Conclusion== | ||
Revision as of 17:33, 24 August 2014
Under Review Journal Club Article
Quinn J. et al.. "Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes". Ann Emerg Med. 2006. 31(26):2992-6.
PubMed Full text PDF
PubMed Full text PDF
Clinical Question
Can the San Francisco Syncope Rule be used in clinical practice to risk stratify patients presenting with syncope?
Conclusion
Major Points
- Criteria (CHESS Pneumonic)[1]
- CHF History
- Hct < 30%
- ECG Abnormality
- SOB history
- SBP < 90mmHg at triage
Study Design
Population
Patient Demographics
Inclusion Criteria
Exclusion Criteria
Interventions
Outcomes
Primary Outcome
Secondary Outcomes
Subgroup analysis
Criticisms & Further Discussion
Funding
Sources
- ↑ Quinn J, McDermott D, Stiell I, Kohn M, Wells G. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med. 2006 May;47(5):448-54. PubMed PMID: 16631985.